FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+12.57%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.28B
AUM Growth
+$165M
(+15%)
Cap. Flow
+$79.4M
Cap. Flow
% of AUM
6.22%
Top 10 Holdings %
Top 10 Hldgs %
52.86%
Holding
80
New
6
Increased
21
Reduced
22
Closed
1
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$26.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$21.4M |
| 3 |
TELA Bio
TELA
|
$17.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$16.3M |
| 5 |
Outset Medical
OM
|
$13.9M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$21.7M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$15.8M |
| 3 |
Krystal Biotech
KRYS
|
$11.1M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.57M |
| 5 |
Keros Therapeutics
KROS
|
$7.12M |
Sector Composition
| 1 | Healthcare | 94.83% |
| 2 | Communication Services | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABCM
26
DELISTED
Abcam plc American Depositary Shares
ABCM
| $17.4M | 1.36% |
710,745
+331,034
| +87% | +$8.1M |
|
|
27
Keros Therapeutics
KROS
$627M
| $16.7M | 1.31% |
416,830
-177,134
| -30% | -$7.12M |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $15.8M | 1.24% |
312,786
+3,546
| +1% | +$179K |
|
|
SCTL
29
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $14.7M | 1.16% |
13,405,030
+4,488,160
| +50% | +$4.94M |
|
30
Tandem Diabetes Care
TNDM
$834M
| $14.7M | 1.16% |
600,767
+11,582
| +2% | +$284K |
|
|
31
Outset Medical
OM
$233M
| $13.9M | 1.09% |
+42,495
| New | +$13.9M |
|
32
Insmed
INSM
$30B
| $13.6M | 1.07% |
645,686
-105,197
| -14% | -$2.22M |
|
33
OrthoPediatrics
KIDS
$513M
| $13.1M | 1.03% |
298,976
-2,603
| -0.9% | -$114K |
|
34
Xenon Pharmaceuticals
XENE
$2.96B
| $13M | 1.02% |
338,646
+59,202
| +21% | +$2.28M |
|
|
35
Krystal Biotech
KRYS
$4.32B
| $11.9M | 0.93% |
101,259
-94,721
| -48% | -$11.1M |
|
|
CUTR
36
DELISTED
Cutera, Inc.
CUTR
| $8.64M | 0.68% |
570,729
+861
| +0.2% | +$13K |
|
37
MaxCyte
MXCT
$143M
| $8.53M | 0.67% |
1,857,566
+493,344
| +36% | +$2.26M |
|
38
Guardant Health
GH
$7.45B
| $7.08M | 0.55% |
197,704
-7,141
| -3% | -$256K |
|
39
AnaptysBio
ANAB
$608M
| $6.55M | 0.51% |
+322,208
| New | +$6.55M |
|
40
Genmab
GMAB
$16.7B
| $6.02M | 0.47% |
158,509
-1,516
| -0.9% | -$57.6K |
|
|
SONX
41
DELISTED
Sonendo, Inc.
SONX
| $5.69M | 0.45% |
4,185,619
| – | – |
|
42
BioMarin Pharmaceuticals
BMRN
$10.9B
| $5.26M | 0.41% |
60,654
-828
| -1% | -$71.8K |
|
43
Pfizer
PFE
$140B
| $5.14M | 0.4% |
140,235
-1,312
| -0.9% | -$48.1K |
|
|
MIRO
44
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $3.9M | 0.31% |
2,225,740
-8,916
| -0.4% | -$15.6K |
|
45
Stevanato
STVN
$6.31B
| $3.7M | 0.29% |
114,276
-1,080
| -0.9% | -$35K |
|
46
Bio-Techne
TECH
$8.14B
| $2.71M | 0.21% |
+33,178
| New | +$2.71M |
|
47
Castle Biosciences
CSTL
$668M
| $2.2M | 0.17% |
160,126
-1,492
| -0.9% | -$20.5K |
|
|
OKUR
48
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.3M
| $1.64M | 0.13% |
+25,000
| New | +$1.64M |
|
49
Simulations Plus
SLP
$288M
| $1.53M | 0.12% |
35,355
-348
| -1% | -$15.1K |
|
50
Smith & Nephew
SNN
$16.4B
| $487K | 0.04% |
15,111
| – | – |
|